Table 1 Summary of the effects and activity of snake venoms (n = 3–6).
Species (scientific name) | Species (common name) | Dose (µg/kg, i.v.) | Maximum decrease in MAP* (%) | Classified as ‘rapid cardiovascular collapse’ | PLA2 activity (nmol/min/ml) | Procoagulant activity (Log EC50) (ng/ml) |
|---|---|---|---|---|---|---|
D. russelii | Sri Lankan Russell’s viper | 100 | 45 ± 8 | No | 1,334 ± 105 | 3.64 ± 0.12 |
D. siamensis | Javanese Russell’s viper | 100 | 35 ± 7 | No | 10,237 ± 1084 | 3.09 ± 0.05 |
B. arietans | Puff adder | 200 | 17 ± 2 | No | 378 ± 46 | N/A |
C. vegrandis | Uracoan rattlesnake | 200 | 11 ± 1 | No | 1,077 ± 38 | 4.75 ± 0.04 |
B. gabonica | Gaboon viper | 200 | 23 ± 3 | No | 3,498 ± 354 | N/A |
E. ocellatus | Carpet viper | 50 | 100 | Yes | 111 ± 8 | 3.26 ± 0.06 |
P. textilis | Brown snake | 5–10 | 100 | Yes | 473 ± 3 | 1.29 ± 0.05 |
